Can a patient taking Eliquis (apixaban) take ibuprofen?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can a Patient Taking Eliquis (Apixaban) Take Ibuprofen?

Patients on Eliquis (apixaban) can technically take ibuprofen, but this combination significantly increases bleeding risk and should be avoided whenever possible, particularly in high-risk patients such as those over 75 years old or with renal impairment (CrCl <50 mL/min). 1

Understanding the Bleeding Risk

The combination of apixaban and NSAIDs like ibuprofen creates a compounded bleeding risk through multiple mechanisms:

  • The FDA explicitly warns that patients should inform their physicians about taking apixaban "and/or any other product known to affect bleeding (including nonprescription products, such as aspirin or NSAIDs)" before any new drug is taken. 2

  • The American Academy of Otolaryngology-Head and Neck Surgery identifies both anticoagulants and NSAIDs as causing increased bleeding episodes, larger blood loss volumes, and higher transfusion requirements. 1

  • Clinical trial data from the ARISTOTLE study demonstrated that incident NSAID use in patients taking apixaban was associated with a 61% increased risk of major bleeding (HR 1.61,95% CI 1.11-2.33) and a 70% increased risk of clinically relevant nonmajor bleeding (HR 1.70,95% CI 1.16-2.48). 3

High-Risk Populations to Avoid This Combination

The American College of Cardiology specifically recommends avoiding NSAID use in high-risk scenarios, including:

  • Elderly patients (>75 years old) 1
  • Patients with renal impairment (CrCl <50 mL/min) 1

Clinical Evidence and Real-World Use

Despite the risks, NSAID use is common among anticoagulated patients:

  • In the ARISTOTLE trial, 4.8% of patients were taking NSAIDs at baseline, and an additional 13.2% started NSAIDs during the trial. 3
  • A cross-sectional survey found that 33% of apixaban users took at least one OTC product with potentially serious interactions daily or most days, with ibuprofen taken occasionally by 28.5% of patients. 4
  • Approximately 66% of patients were either uncertain or incorrect about the potential for increased bleeding from combining NSAIDs and apixaban. 4

Safer Alternative: Acetaminophen

Acetaminophen (paracetamol) is considered safe with apixaban and does not increase bleeding risk, making it the preferred alternative for pain relief. 5

If Ibuprofen Must Be Used

When ibuprofen cannot be avoided, implement these risk mitigation strategies:

  • Use the lowest effective dose for the shortest duration possible 6
  • Monitor closely for signs of bleeding: unusual bruising, prolonged bleeding from cuts, blood in urine or stool, unexplained bleeding, hematemesis, melena, or hemodynamic instability 5, 2
  • Educate patients to seek emergency care immediately for any unusual or severe bleeding 5, 2
  • Consider the patient's baseline bleeding risk factors: history of prior bleeding, concomitant antiplatelet use, age, and renal function 3

Common Pitfalls to Avoid

  • Do not assume OTC ibuprofen is "safe" simply because it doesn't require a prescription - the bleeding risk is real and clinically significant 3, 4
  • Do not overlook chronic ibuprofen use - patients may not volunteer information about regular OTC NSAID use unless specifically asked 4
  • Do not forget that the risk increases with concomitant use of other bleeding-risk medications such as aspirin, other antiplatelet agents, or SSRIs 2, 3

Important Note on Drug Interactions

While the ARISTOTLE trial found no significant interaction between NSAID use and the comparative safety/efficacy of apixaban versus warfarin, this does not mean the combination is safe - it simply means both anticoagulants carry similar increased bleeding risk when combined with NSAIDs. 3

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.